Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash & Current Investments: 2016-2024

Historic Cash & Current Investments for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $162.8 million.

  • Collegium Pharmaceutical's Cash & Current Investments rose 138.30% to $285.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $868.6 million, marking a year-over-year decrease of 14.86%. This contributed to the annual value of $162.8 million for FY2024, which is 47.59% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Cash & Current Investments of $162.8 million as of FY2024, which was down 47.59% from $310.5 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Cash & Current Investments peaked at $310.5 million during FY2023, and registered a low of $162.8 million during FY2024.
  • Moreover, its 3-year median value for Cash & Current Investments was $173.7 million (2022), whereas its average is $215.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 78.80% in 2023, then tumbled by 47.59% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Cash & Current Investments (Yearly) stood at $174.1 million in 2020, then increased by 7.07% to $186.4 million in 2021, then fell by 6.83% to $173.7 million in 2022, then spiked by 78.80% to $310.5 million in 2023, then slumped by 47.59% to $162.8 million in 2024.